Tohoku University

The article content provided is empty and does not contain any text to summarize.

Takeda focuses on better health and future through life-transforming treatments. Tohoku University, founded in 1907, aims for innovative research and human resource development, establishing the Drug Discovery Strategy Promotion Organization in 2023 for collaborative research. Tohoku University Hospital promotes advanced medical care and international-level clinical research.

Researchers at Tohoku University discovered a mechanism where atomic jumps and collective motion in glass reduce internal stress, making it more resistant to breakage, with implications for various industries. Published in 'Acta Materialia' on December 2, 2024.

PDBj and ToMMo launch a portal linking genetic variant data from the Tohoku Medical Megabank Project with protein sequence and structural information, simplifying the visualization of variants on protein 3D structures and aiming to evolve into a comprehensive platform for precision medicine.

FT825 / ONO-8250, a CAR T-cell product targeting HER2, showed favorable safety and efficacy in Phase 1 solid tumor study, with no dose-limiting toxicities observed. Preclinical data highlighted its cancer-selective recognition profile, targeting HER2 variants uniquely expressed on tumor cells.

FT825 / ONO-8250, a CAR T-cell product targeting HER2, showed favorable safety and efficacy in Phase 1 solid tumor study, with no dose-limiting toxicities observed. Preclinical data highlighted the cancer-selective recognition profile of its novel HER2 antigen binding domain, derived from H2CasMab-2, which preferentially targets tumor cells.

Japanese researchers created a superconducting flux qubit using a ferromagnetic Josephson junction (π-junction), functioning without an external magnetic field. This innovation simplifies circuits, reduces noise, and enhances qubit integration, potentially leading to high-performance quantum computers.

A research team led by Professor Hiroshi Yabu increased capacitor capacity by 2.4 times using iron azaphthalocyanine on activated carbon, achieving 907 F/gAC and 20,000 charge-discharge cycles at 20 A/gAC, potentially reducing waste and toxicity compared to batteries.